Sort
82,697 grants matching “vaccine development”
NIDA Clinical Trials Network: Greater New York Node
$871,690John P Rotrosen · New York University School Of Medicine · UG1 · FY2015 · DA
Discovery of Molecules to disrupt the outer membrane of Gram-negative pathogens
$871,618Daniel E Kahne · Harvard Medical School · U19 · FY2014 · AI
Vaccine and Treatment Evaluation Units (VTEU)
$871,600Hana M El Sahli · Baylor College Of Medicine · UM1 · FY2022 · AI
Animal Core
$871,476David S Perlin · Columbia University Health Sciences · U54 · FY2010 · AI
Transcutaneous Immunization for Tetanus Booster
$871,356Iomai Corporation · R44 · FY2002 · AI
SOUTHERN AFRICA-NEW YORK HIV VACCINE TRIALS UNIT
$871,348Medical Research Council Of South Africa · U01 · FY2004 · AI
Integrated Multi-omics of Melioidosis
$871,221Timothy Eoin West · University Of Washington · R01 · FY2019 · AI
TOWARDS A MORE RELEVANT MODEL OF HIV INFECTION
$871,200Julie M Overbaugh · Fred Hutchinson Cancer Research Center · DP1 · FY2016 · DA
Novel Concepts for the Eradication of HIV
$871,184Rafick-Pierre Sekaly · Vgti Florida · DP1 · FY2013 · DA
Human EGFRvIII-specific BiTE for the treatment of Glioblastoma
$871,073John H Sampson · Duke University · U01 · FY2019 · NS
Project 1: Development of Nucleoside-Modified mRNAs Encoding Sequential HIV-1 Envelopes for Initiation of V3-glycan Neutralizing Antibody Lineages
$871,042Barton F Haynes · Duke University · U19 · FY2020 · AI
The Evaluation of Novel Therapeutics for Genitourinary Malignancies
$871,023William Laurence Dahut · Division Of Clinical Sciences - Nci · ZIA · FY2017 · CA
Alphavirus Vaccines for Biodefense
$870,993Scott C Weaver · University Of Texas Med Br Galveston · U54 · FY2010 · AI
Molecular analysis of the mucosal SIVsmm transmission bottleneck
$870,987George M Shaw · University Of Pennsylvania · P01 · FY2014 · AI
Modulation of Viral Antigen Presentation in the Lung
$870,979Anna Karolina Palucka · Jackson Laboratory · U19 · FY2023 · AI
An OpenData Portal to share SARS-CoV-2 drug repurposing data in real time
$870,948Matthew Hall · National Center For Advancing Translational Sciences · ZIA · FY2024 · TR
Improving the pharmacokinetics, potency, and immunogenicity of eCD4-Ig
$870,946Michael David Alpert · Emmune, Inc · R44 · FY2021 · AI
A Tetravalent Dengue Vaccine Based on Alphavirus Replicons
$870,945Laura J White · Univ Of North Carolina Chapel Hill · U01 · FY2009 · AI
Safety and efficacy of PfSPZ malaria vaccine in malaria-exposed adults
$870,936Christopher V. Plowe · University Of Maryland Baltimore · U01 · FY2017 · AI
Development of tissue explant models for microbicide evaluation
$870,770Thomas Hope · Northwestern University At Chicago · R33 · FY2010 · AI
A multi-tiered approach to develop validated assays to predict efficacy of a tetravalent live attenuated Dengue Virus vaccine in Phase II and Phase III clinical trials
$870,724Rafick-Pierre Sekaly · Case Western Reserve University · R01 · FY2019 · AI
Once Bitten: Acquisition of Malaria Adaptive Immunity (OBAMA - Immunity)
$870,556Wendy Prudhommeomeara · Duke University · R01 · FY2023 · AI
Dissecting Polyclonal Sera to Reveal Correlates of Productive Immune Responses to HIV
$870,554Andrew Barrett Ward · Scripps Research Institute, The · R01 · FY2023 · AI
Function of granulysin
$870,505Alan Krensky · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Immunoprevention and immunosurveillance of human non-viral cancers
$870,445Olivera J Finn · University Of Pittsburgh At Pittsburgh · R35 · FY2019 · CA